Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
出版年份 2013 全文链接
标题
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
作者
关键词
-
出版物
BLOOD
Volume 122, Issue 15, Pages 2664-2672
出版商
American Society of Hematology
发表日期
2013-08-17
DOI
10.1182/blood-2013-02-485425
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells
- (2012) F. Forconi et al. BLOOD
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies
- (2012) A. Cesano et al. HAEMATOLOGICA
- Cellular origin and pathophysiology of chronic lymphocytic leukemia
- (2012) Marc Seifert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells
- (2011) S. Krysov et al. BLOOD
- B-cell receptor signaling in chronic lymphocytic leukemia
- (2011) F. K. Stevenson et al. BLOOD
- Unknown
- (2011) Carlo Calissano et al. MOLECULAR MEDICINE
- Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
- (2011) Jan A. Burger Current Hematologic Malignancy Reports
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- Impact of the host genetic background on prognosis of chronic lymphocytic leukemia
- (2010) S. Rasi et al. BLOOD
- Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities
- (2010) N. Chiorazzi et al. BLOOD
- BCR-Mediated Decrease of CXCR4 and CD62L in CLL – Letter
- (2010) Maite P. Quiroga et al. CANCER RESEARCH
- Molecular underpinning of B-cell anergy
- (2010) Yuval Yarkoni et al. IMMUNOLOGICAL REVIEWS
- CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL
- (2010) Aneela Majid et al. LEUKEMIA RESEARCH
- Antigens in chronic lymphocytic leukemia—Implications for cell origin and leukemogenesis
- (2010) Anders Rosén et al. SEMINARS IN CANCER BIOLOGY
- Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting
- (2010) Jan A. Burger SEMINARS IN CANCER BIOLOGY
- The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL
- (2009) F. Forconi et al. BLOOD
- In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia
- (2009) C. Calissano et al. BLOOD
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- The microenvironment in mature B-cell malignancies: a target for new treatment strategies
- (2009) J. A. Burger et al. BLOOD
- The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
- (2009) Davide Rossi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease
- (2009) A. Vlad et al. CANCER RESEARCH
- Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors
- (2008) J. Andrew Duty et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More